Abstract
This chapter will review current understanding of two neurodevelopmental disorders involving dysregulation of executive (frontal lobe) functioning: Attention-Deficit/Hyperactivity Disorder (ADHD), and Tourette Disorder (TD). It will describe the clinical phenomenology of these disorders (including co-occurring conditions), recent research into their neurobiological and neuropsychological mechanisms, recommended assessment procedures, medical treatments, and psychosocial interventions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Roberts W, Milich R, Barkley RA. Primary symptoms, diagnostic criteria, subtyping and prevalence of ADHD. In: Barkley RA, editor. Attention deficit hyperactivity disorder: a handbook for diagnosis and treatment. 4th ed. New York, NY: Guilford Press; 2014.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
Nigg J. What causes ADHD?. New York, NY: Guilford Press; 2006.
Bralten J, Franke B, Waldman I, et al. Candidate genetic pathways for attention-deficit/hyperactivity disorder (ADHD) show association to hyperactive/impulsive symptoms in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2013;52(1204):12.e1.
Faraone SV, Asherson P, Banaschewski T, et al. Attention-deficit/hyperactivity disorder. Nat Rev Dis Primer. 2015;1:1–22.
Neuman RJ, Lobos E, Reich W. Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biol Psychiatry. 2007;61:1320–8.
Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci. 1986;9:357–81.
Zhu Y, Yang D, Ji W. The relationship between neurocircuitry dysfunctions and attention deficit hyperactivity disorder: a review. BioMed Res Int. 2016;1–7. http://dx.doi.org/10.1155/2016/3821579.
Arnsten AFT. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. J Clin Psychiatry. 2006;67:7–12.
Gaddis A, Rosch KS, Dirlikov B, et al. Motor overflow in children with attention-deficit/hyperactivity disorder is associated with decreased extent of neural activation in the motor cortex. Psychiatry Res. 2015;233:488–95.
Gilbert DL, Issacs KM, Augusta M, Macneil LK, Mostofsky SH. Motor cortex inhibition: a marker of ADHD behavior and motor development in children. Neurology. 2011;76:615–21.
Armstrong CL, Hayes KM, Martin R. Neurocognitive problems in attention deficit disorder: alternative concepts and evidence for impairment in inhibition of selective attention. Ann NY Acad Sci. 2001;931(1, theme issue):196–215.
Petersen SE, Posner MI. The attention system of the human brain: 20 years after. Annu Rev Neurosci. 2012;35:73–89.
Arnsten AFT, Rubia K. Neurobiological circuits regulating attention, cognitive control, motivation and emotion: disruption in neurodevelopmental psychiatric disorders. J Am Acad Child Adolesc Psychiatry. 2012;51:356–67.
Pennington BF. Explaining abnormal behavior: a cognitive neuroscience perspective. New York, NY: Guilford Press; 2014.
Wasserstein J, Stefanatos GA. Re-examining ADHD as corticostriatal disorder: implications for understanding common comorbidities. ADHD Rep. 2016;24:1–10.
Castellanos FX, Proal E. Large-scale brain systems in ADHD: beyond the prefrontal-striatal model. Trends Cogn Sci. 2011;16:7–26.
Pliszka SR, Glahn DC, Semrud-Clikeman M, et al. Neuroimaging of inhibitory control areas in children with attention deficit hyperactivity disorder who were treatment naïve or in long-term treatment. Am J Psychiatry. 2006;164:942–8.
Pliszka SR. Neuroscience for the mental health clinician. 2nd ed. New York, NY: Guilford Press; 2016.
Cortese S, Kelly C, Chabernaud C, et al. Neuroscience of ADHD: a meta-analysis of 55 fMRI studies. J Am Psychiatry. 2012;169:1–28.
Farrant K, Uddin LQ. Asymmetric development of dorsal and ventral attention networks in the human brain. Dev Cogn Neurosci. 2015;12:165–74.
Posner J, Park C, Wang Z. Connecting the dots: a review of resting connectivity MRI studies in attention-deficit/hyperactivity disorder. Neuropsychol Rev. 2014;24:3–15.
Zillmer EA, Spiers MV, Culbertson WC. Principles of neuropsychology. 2nd ed. Belmont, CA: Waldworth; 2008.
Zametkin AJ, Nordahl TE, Gross M, et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. New Engl J Med. 1990;323:1361–6.
Shaw P, Eckstrand K, Sharp W, et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Nat Acad Sci. 2007;104:19649–54.
Shaw P, Malek M, Watson B, Sharp W, Evans A, Greenstein D. Development of cortical surface area and gyrification in attention-deficit/hyperactivity disorder. Biol Psychiatry. 2012;72:191–7.
Shaw P, De Rossi P, Watson B, et al. Mapping the development of the basal ganglia in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2014;53:780–90.
Plichta MM, Scheres A. Ventral-striatal responsiveness during reward anticipation in ADHD and its relation to trait impulsivity in the healthy population: a meta-analytic review of the fMRI. Neurosci Biobehav Rev. 2014;38:125–34.
Willcutt EG. Theories of ADHD. In: Barkley RA, editor. Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment. 4th ed. New York, NY: Guilford Press; 2015. p. 391–404.
Hien D, Matzner FJ, First MB, Spitzer RL, Williams J, Gibbon M. Structured clinical interview for DSM-IV childhood diagnoses (KID-SCID). New York, NY: Biometrics Research; 1994.
Khan K, Sharief N. Chronic carbon monoxide poisoning in children. Acta Paediatrica. 1995;84:742.
Armstrong CL, Cunningham J. Functional and developmental effects of environmental CO toxicity in children. In: Penney D, editor. Carbon monoxide toxicity. Boca Raton, FL: CRC Press; 2007.
Daneshparvar M, Mostafavi SA, Jeddi MZ, et al. The role of lead exposure on attention-deficit/hyperactivity disorder ‎in children: a systematic review. Iran J Psychiatry. 2016;11:1–14.
Nigg JT, Elmore AL, Natarajan N, Friderici KH, Nikolas MA. Variation in an iron metabolism gene moderates the association between blood lead levels and attention-deficit/hyperactivity disorder in children. Psychol Sci. 2016;27:257–69.
Wilkinson GS, Robertson GJ. Wide range achievement test. 5th ed. New York, NY: Pearson Inc.; 2017.
Beery KE, Buktenica NA, Beery NA. Beery VMI developmental test of visual-motor integration. 6th ed. North Tonawanda, NY: Multi-Health Systems; 2010.
Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1997;36(suppl):85S–121S.
Faraone SV, Buitelaar J. Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur Child Adolesc Psychiatry. 2010;19:353–64.
Shaw M, Hodgkins P, Caci H, et al. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med. 2012;10:99–114.
Barkley RA, editor. Attention Deficit Hyperactivity disorder: a handbook for diagnosis and treatment. 4th ed. New York, NY: Guilford Press; 2014.
Wolraich M, Brown L, Brown RT, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128:1007–22.
Tanaka Y, Rohde LA, Jin L, Feldman PD, Upadhyaya HP. A meta-analysis of the consistency of atomoxetine treatment effects in pediatric patients with attention-deficit/hyperactivity disorder from 15 clinical trials across four geographic regions. J Child Adolesc Psychopharmacol. 2013;23:262–70.
Bushe CJ, Savill NC. Systematic review of atomoxetine data in childhood and adolescent attention-deficit hyperactivity disorder 2009–2011: focus on clinical efficacy and safety. J Psychopharmacol. 2014;28:204–11.
Clemow DB, Bushe CJ. Atomoxetine in patients with ADHD: a clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients. J Psychopharmacol. 2015;29:1221–30.
Treuer T, Shur-Fen Gau S, Mendez L, et al. A systematic review of combination therapy with stimulants and atomoxetine for attention deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability. J Child Adolesc Psychopharmacol. 2013;23:179–93.
Biederman J, Melmed RD, Patel A, McBurnett K, Donahue J, Lyne A. Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD. CNS Spectrums. 2008;13:1047–55.
Jain R, Segal S, Kollins SH, Khayrallah M. Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2011;50:171–9.
Faraone SV, McBurnett K, Sallee FR, Steeber J, Lopez FA. Guanfacine extended release: a novel treatment for attention-deficit/hyperactivity disorder in children and adolescents. Clin Ther. 2013;35:1778–93.
Evans SW, Owens JS, Bunford N. Evidenced-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol. 2014;43:527–51.
Leckman JF. Phenomenology of tics and sensory urges. In: Martino D, Leckman JF, editors. Tourette syndrome. New York, NY: Oxford University Press; 2013. p. 3–25.
Martino D, Madhusudan N, Zis P, Cavanna AE. An introduction to the clinical phenomenology of Tourette syndrome. Int Rev Neurobiol. 2013;112:2–25.
Peterson BS, Leckman JF. The temporal dynamics of tics in Gilles de la Tourette syndrome. Biol Psychiatr. 1998;44:1337–48.
Cavanna AE, Black KJ, Hallett M, Voon V. Neurobiology of the premonitory urge in Tourette syndrome: pathophysiology and treatment implications. J Neuropsychiatr Clin Neurosci. 2017;29:95–104.
Bloch MH, Leckman JF. Clinical course of Tourette syndrome. Psychosom Res. 2009;67:497–501.
Singer HSS. Tourette’s syndrome: from behaviour to biology. Lancet Neurol. 2005;4:149–59.
Leckman JF, King RA, Bloch MH. Clinical features of Tourette syndrome and tic disorders. J Obsessive-Compuls Rel Dis. 2014;3:372–9.
Leckman JF, Walker WK, Goodman WK, Pauls DL, Cohen DJ. ‘Just right’ perceptions associated with compulsive behaviors in Tourette’s syndrome. Am J Psychiatry. 1994;151:675–80.
Worbe Y, Mallet L, Goldmard J-L, et al. Repetitive behavior in patients with Gilles de la Tourette Syndrome: tics, compulsions, or both? PLOS One. 2010;5(9):e12959.
Robertson MM. A personal 35-year perspective on Gilles de la Tourette syndrome: prevalence, phenomenology, comorbidities, and coexistent psychopathologies. Lancet Psychiatr. 2015;2:68–87.
Knight T, Steeves T, Day L, Lowerison M, Jette N, Pringsheim T. Prevalence of tic disorders: a systematic review and meta-analysis. Pediatr Neurol. 2012;47:77–90.
Scharf JM, Miller LL, Gauvin CA, Alabiso J, Mathews CA, Ben-Shlomo Y. Population prevalence of Tourette syndrome: a systematic review and meta-analysis. Mov Dis. 2015;30:221–8.
Pauls DL, Fernandez TV, Mathews CA, State MW, Scharf JM. The inheritance of Tourette disorder: a review. J Obsessive Compuls Relat Disord. 2014;3:380–5.
Browne HA, Hansen SN, Buxbaum JD, et al. Familial clustering of tic disorders and obsessive-compulsive disorder. JAMA Psychiatry. 2015;72:359–66.
Mataix-Cols D, Isomura K, Pérez-Vigil A, et al. Familial risks of Tourette syndrome and chronic tic disorders: a population-based cohort study. JAMA Psychiatry. 2015;72:787–93.
Abelson JF, Kwan KY, O’Roak BJ, et al. Sequence variants in SLITRK1 are associated with Tourette’s syndrome. Science. 2005;310:317–20.
O’Roak BJ, Morgan TM, Fishman DO, et al. Additional support for the association of SLITRK1 var321 and Tourette syndrome. Mol Psychiatry. 2010;15:447–50.
Karagiannidis I, Rizzo R, Tarnok Z, et al. Replication of association between a SLITRK1 haplotype and Tourette syndrome in a large sample of families. Mol Psychiatry. 2012;17:665–8.
Stillman AA, Krsnik Z, Sun J, et al. Developmentally regulated and evolutionarily conserved expression of SLITRK1 in brain circuits implicated in Tourette syndrome. J Comp Neurol. 2009;513:21–37.
Scharf JM, Moorjani P, Fagerness J, et al. Lack of association between SLITRK1 var321 and Tourette syndrome in a large family-based sample. Neurology. 2008;70:1495–6.
Robertson MM, Eapen V, Singer HS, et al. Gilles de la Tourette syndrome. Nat Rev Dis Primers. 2017;3:1–20.
Murphy TF, Gerardi DM, Leckman JF. Pediatric acute-onset neuropsychiatric syndrome. Psychiatr Clin North Am. 2014;37:353–74.
Chang K, Frankovich J, Cooperstock M, et al. Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS consensus conference. J Child Adolesc Psychopharmacol. 2015;25:3–13.
Thienemann M, Murphy T, Leckman J, et al. Clinical management of pediatric acute-onset neuropsychiatric syndrome: part I—psychiatric and behavioral interventions. J Child Adolesc Psychopharmacol. 2017;27:566–73.
Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155:264–71.
Marsh R, Maia TV, Peterson BS. Functional disturbances within frontostriatal circuits across multiple childhood psychopathologies. Am J Psychiatry. 2009;166:664–74.
Jackson GM, Draper A, Dyke K, Pépés SE, Jackson SR. Inhibition, disinhibition, and the control of action in Tourette syndrome. Trends Cogn Sci. 2015;19:655–65.
Polyanska L, Critchley HD, Rae CL. Centrality of prefrontal and motor preparation cortices to Tourette, syndrome revealed by meta-analysis of task-based neuroimaging studies. NeuroImage Clin. 2017;16:257–67.
Albin RL, Koeppe RA, Bohnen NI, et al. Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology. 2003;61:310–5.
Buse J, Schoenefeld K, Münchau A, Roessner V. Neuromodulation in Tourette syndrome: dopamine and beyond. Neurosci Behav Rev. 2013;37:1069–84.
Kurlan R, Como PG, Miller B, et al. The behavioral spectrum of tic disorders: a community-based study. Neurol Clin. 2002;59:414–20.
O’Rourke JA, Scharf JM, Platko J, et al. The familial association of Tourette’s disorder and ADHD: the impact of OCD symptoms. Am J Med Genet B Neuropsychiatr Genet. 2011;156:432–8.
Hassan N, Cavanna AE. The prognosis of Tourette syndrome: implications for clinical practice. Funct Neurol. 2012;27:23–7.
Shaw ZA, Coffey BJ. Tics and Tourette syndrome. Psychiatr Clin North Am. 2014;37:269–86.
Freeman R, Fast D, Burd L, Kerbeshian J, Robertson M, Sandor P. An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol. 2000;42:436–47.
Budman CL, Rockmore L, Bruun RD. Aggressive symptoms in Tourette’s syndrome. In: Kurlan R, editor. Handbook of Tourette’s syndrome and related tic and behavioral disorders. 2nd ed. New York, NY: Marcel Dekker; 2005. p. 127–54.
Como PC. Neuropsychological function in Tourette’s syndrome. In: Kurlan R, editor. Handbook of Tourette’s syndrome and related tic and behavioral disorders. 2nd ed. New York, NY: Marcel Dekker; 2005. p. 237–52.
Morand-Beaulieu S, Leclerc JB, Valois P, Lavoie ME, O’Connor KP, Gauthier B. A review of the neuropsychological dimension ns of Tourette syndrome. Brain Sci. 2017;7:106. https://doi.org/10.3390/brainsci7080106.
Channon S, Pratt P, Robertson MM. Executive function, memory and learning in Tourette’s syndrome. Neuropsychology. 2003;17:247–54.
Eddy CM, Rickard HE, Cavanna AE. Executive functions in uncomplicated Tourette syndrome. Psychiatry Res. 2012;200:46–8.
Morand-Beaulieu S, Grot S, Lavoie J, Leclerc JB, Luck D, Lavoie ME. The puzzling question of inhibitory control in Tourette syndrome: a meta-analysis. Neurosci Biobehav Rev. 2017;80:240–62.
Yaniv A, Benaroya-Milshtein N, Steinberg T, Ruhrrman D, Apter A, Lavidor M. Specific executive control impairments in Tourette syndrome: the role of response inhibition. Res Dev Dis. 2017;61:1–10.
Jeter CB, Patel SS, Morris JS, Chuang AZ, Butler IJ, Sereno AB. Oculomotor executive function abnormalities with increased tic severity in Tourette syndrome. J Child Psychol Psychiatry. 2015;56:193–202.
Eddy CM, Cavanna AE. Altered social cognition in Tourette syndrome: nature and implications. Behav Neurol. 2013;7:15–22.
Eddy CM, Macerollo A, Martino D, Cavanna AE. Interpersonal reactivity differences in Tourette syndrome. Psychiatry Res. 2015;228:922–35.
Zinner SH, Conelea CA, Glew GM, Woods DW, Budman CL. Peer victimization in youth with Tourette syndrome and other chronic tic disorders. Child Psychiatry Human Dev. 2012;43:124–36.
Hirschtritt ME, Lee PC, Pauls DL, et al. Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome. JAMA Psychiatry. 2015;72:325–33.
McGuire JF, Hanks C, Kewin AB, Storch EA, Murphy TK. Social deficits in children with chronic tic disorders: phenomenology, clinical correlates and quality of life. Compr Psychiatry. 2013;54:1023–31.
Channon S, Sinclair E, Waller D, Healey L, Robertson MM. Social cognition in Tourette’s syndrome: intact theory of mind and impaired inhibitory functioning. J Autism Dev Disord. 2004;34:669–77.
Güler AS, Berkem M, Yazgan Y, Kalaça S. Cognitive flexibility and social responsiveness in children and adolescents with Tourette syndrome. Child Psychiatry Human Dev. 2015;46:940–50.
Specht MW, Chang SW. Tourette’s disorder and other tic disorders. In: Reddy LA, Weissman AS, Hale JB, editors. Neuropsychological assessment and intervention for youth: an evidence-based approach to emotional and behavioral disorders. Washington, DC: American Psychological Association; 2013. p. 201–24.
Leckman JF, Riddle MA, Hardin MT, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989;28:566–73.
Scahill L, Riddle MA, McSwiggin-Hardin M, et al. The children’s Yale Brown obsessive compulsive scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997;36:844–52.
March JS. Multidimensional anxiety scale for children, 2nd ed. North Tonawanda, NY: Multi-Health Systems; 2013.
Spielberger CD, Edwards CD, Montouri J, Lushene R. The state-trait anxiety inventory for children (STAI-CH). Menlo Park, CA: Mind Garden Inc.; 1970.
Kovacs M. Children’s depression inventory. 2nd ed. North Tonawanda, NY: Multi-Health Systems; 2010.
Poznanski EO, Mokros HB. Children’s depression rating scale, revised (CDRS-R). Torrance, CA: WPS; 1996.
DuPaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD rating scale for children and adolescents: checklists, norms, and clinical interpretation. 5th ed. New York, NY: Guilford Press; 2016.
Conners CK. Conners, 3rd ed (Conners 3). North Tonawanda, NY: Multi-Health Systems; 2008.
Barkley RA, Murphy KR, Fischer M. Adult ADHD symptom checklist. Adult ADHD: what the science says. New York, NY: Guilford Press; 2008.
Khalifa N, Eklund S. Fine motor functioning and perception in children with Tourette syndrome. J Childhood Dev Disord. 2017;3:1–7.
Piacentini J, Chang S. Habit reversal training for tic disorders in children and adolescents. Behav Modif. 2005;29:803–22.
Frank M, Cavanna AE. Behavioural treatments for Tourette syndrome: an evidence-based review. Behav Neurol. 2013;27:105–17.
Fründt O, Woods D, Ganos C. Behavioral therapy and Tourette syndrome and chronic tic disorders. Neurol Clin Pract. 2017;7. https://doi.org/10.1212/CPJ.0000000000000348.
McGuire JF, Picentini J, Brennan EA, et al. A meta-analysis of behavior therapy for Tourette syndrome. J Psychiatr Res. 2014;50:106–12.
McGuire JF, Ricketts EJ, Piacentini J, Murphy TK, Storch EA, Lewin AB. Behavior therapy for tic disorders: an evidenced-based review and new directions for treatment research. Curr Dev Disord Rep. 2015;2:309–17.
Piacentini J, Woods DW, Scahill L, et al. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA. 2010;303:1929–37.
Conelea CA, Walther MR, Freeman JB, et al. Tic-related obsessive-compulsive disorder (OCD): phenomenology and treatment outcome in the pediatric OCD treatment study II. J Am Acad Child Adolesc Psychiatry. 2017;53:1308–16.
Greene RW, Ablon JS. Treating explosive kids: the collaborative problem solving approach. New York, NY: Guilford Press; 2006.
Budman C. The role of atypical antipsychotics for treatment of Tourette’s syndrome: an overview. Drugs. 2014;74:1177–93.
Srour M, Lesperance P, Richer F, Chouinard S. Psychopharmacology of tic disorders. J Canad Acad Child Adolesc Psychiatry. 2008;17:150–9.
Thomas R, Cavanna AE. The pharmacology of Tourette syndrome. J Neural Transm. 2013;120:689–94.
Weisman H, Qureshi IA, Leckman JF, Scahill L, Bloch MH. Systematic review: pharmacological treatment of tic disorders - efficacy of antipsychotic and alpha-2 adrenergic agonist agents. Neurosci Biobehav Rev. 2013;37:1162–71.
Tourette Syndrome Study Group. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology. 2002;58:527–36.
Spencer TJ, Sallee FR, Gilbert DL. Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome. J Atten Disord. 2008;11:470–81.
Martinez-Ramirez D, Simenez-Shahed J, Leckman JF, et al. Efficacy and safety of deep brain stimulation in Tourette syndrome. JAMA Neurol. 2018. https://jamanetwork.com/journals/jamaneurology/fullarticle/2669923.
Servello D, Porta M, Sassi M, Brambilla A, Robertson MM. Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation. J Neurol Neurosurg Psychiatry. 2008;79:136–42.
Maciunas RJ, Maddux BN, Riley DE, et al. Prospective randomized double-blind trial of bilateral thalamic deep brain stimulation in adults with Tourette’s syndrome. J Neurosurg. 2007;107:1004–14.
Andrade P, Visser-Vandewalle V. DBS in Tourette syndrome: where are we standing now? J Neural Trans (Vienna). 2016;123:791–6.
Kwon HJ, Lim WS, Lim MH, et al. 1-Hz low frequency repetitive transcranial magnetic stimulation in children with Tourette’s syndrome. Neurosci Lett. 2011;492:1–4.
Le K, Liu L, Sun M, Hu L, Xiao N. Transcranial magnetic stimulation at 1 Hertz improves clinical symptoms in children with Tourette syndrome for at least 6 months. J Clin Neurosci. 2013;20:257–62.
Kious BM, Jimenez-Shahed J, Shprecher DR. Treatment-refractory Tourette syndrome. Progress Neuro-Psychopharmacol Biol Psychiatry. 2016;70:227–36.
Bloch MH, Peterson BS, Scahill L, et al. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Arch Pediatr Adolesc Med. 2006;160:65–9.
Acknowledgments
The authors wish to acknowledge Lisa Tuttle, M.A. for her assistance with formatting the references for this manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rostain, A.L., Culbertson, W.C. (2019). Executive Function Disorders in Pediatric Neuropsychology: Attention-Deficit/Hyperactivity Disorder and Tourette Disorder. In: Armstrong, C., Morrow, L. (eds) Handbook of Medical Neuropsychology. Springer, Cham. https://doi.org/10.1007/978-3-030-14895-9_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-14895-9_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-14894-2
Online ISBN: 978-3-030-14895-9
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)